Kumar Dhanasekharan
Chief Tech/Sci/R&D Officer at RENOVACOR, INC.
Kumar Dhanasekharan active positions
| Companies | Position | Start | End |
|---|---|---|---|
| RENOVACOR, INC. | Chief Tech/Sci/R&D Officer | 2021-10-03 | - |
Career history of Kumar Dhanasekharan
Former positions of Kumar Dhanasekharan
| Companies | Position | Start | End |
|---|---|---|---|
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Corporate Officer/Principal | - | - |
Training of Kumar Dhanasekharan
| Rutgers University, Camden | Doctorate Degree |
| Indian Institute of Technology Madras | Undergraduate Degree |
Statistics
International
| United States | 4 |
| India | 2 |
Operational
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Renovacor, Inc.
 Renovacor, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA. | Health Technology |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Health Technology |
- Stock Market
- Insiders
- Kumar Dhanasekharan
- Experience
